Product Information
ARNUITY ELLIPTA 50 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $6.6434 per EA under NDC 00173088810. Its NADAC has been published 367 times since Jun 19, 2019.
Strength
50 ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173088810
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
FLUTICASONE FUROATEApproval Type
New Drug (NDA)
FDA Application
NDA205625On Market Since
5/17/2018
Pharmacological Classes
Price Statistics
The NADAC for ARNUITY ELLIPTA 50 MCG INH has been published 367 times since Jun 19, 2019, and over the history we have for it it has risen 19.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6434 per EA |
|---|---|
| All-time high | $6.7215 (Apr 10, 2024) |
| All-time low | $5.5399 (Jun 19, 2019) |
| 52-week high | $6.6586 |
| 52-week low | $6.6434 |
| Median price | $6.3722 |
| Average price | $6.2664 |
| Largest weekly change | +4.9% (Jul 13, 2022) |
| Weeks tracked | 367 |
| Tracking since | Jun 19, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 36% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ARNUITY ELLIPTA 50 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for ARNUITY ELLIPTA 50 MCG INH, manufactured by GlaxoSmithKline LLC, is $6.6434 per EA (NDC 00173088810), effective Jun 24, 2026.
How has the price of ARNUITY ELLIPTA 50 MCG INH changed over time?
Over the history we have for it, the NADAC for ARNUITY ELLIPTA 50 MCG INH has risen 19.9%. It has been tracked across 367 weekly CMS publications since Jun 19, 2019.
What are the highest and lowest recorded NADAC prices for ARNUITY ELLIPTA 50 MCG INH?
Since Jun 19, 2019, the NADAC for ARNUITY ELLIPTA 50 MCG INH has ranged from a low of $5.5399 (Jun 19, 2019) to a high of $6.7215 (Apr 10, 2024), with a median of $6.3722 per EA.
Are there cheaper alternatives to ARNUITY ELLIPTA 50 MCG INH?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, FLUTICASONE ELLIPTA 50 MCG INH, is $4.2190 per EA — about 36% below ARNUITY ELLIPTA 50 MCG INH.
Who manufactures ARNUITY ELLIPTA 50 MCG INH?
ARNUITY ELLIPTA 50 MCG INH (NDC 00173088810) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification